The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Artificial Cardiopulmonary Machine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2028
Synopsis
The Artificial Cardiopulmonary Machine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Artificial Cardiopulmonary Machine market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Cardiac Surgery accounting for % of the Artificial Cardiopulmonary Machine global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Single Roller Pump HLM segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Artificial Cardiopulmonary Machine include LivaNova (Sorin), Getinge (Maquet), Medtronic, Terumo CV Group, and Braile Biomedica, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Artificial Cardiopulmonary Machine market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Single Roller Pump HLM
Double Roller Pump HLM
Market segment by Application can be divided into
Cardiac Surgery
Lung Transplant Operation
Acute Respiratory Failure Treatment
Others
The key market players for global Artificial Cardiopulmonary Machine market are listed below:
LivaNova (Sorin)
Getinge (Maquet)
Medtronic
Terumo CV Group
Braile Biomedica
Tianjin Medical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Artificial Cardiopulmonary Machine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Artificial Cardiopulmonary Machine, with price, sales, revenue and global market share of Artificial Cardiopulmonary Machine from 2019 to 2022.
Chapter 3, the Artificial Cardiopulmonary Machine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Artificial Cardiopulmonary Machine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Artificial Cardiopulmonary Machine market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Artificial Cardiopulmonary Machine.
Chapter 13, 14, and 15, to describe Artificial Cardiopulmonary Machine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Geographical Area
Global
The Artificial Cardiopulmonary Machine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Artificial Cardiopulmonary Machine market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Cardiac Surgery accounting for % of the Artificial Cardiopulmonary Machine global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Single Roller Pump HLM segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Artificial Cardiopulmonary Machine include LivaNova (Sorin), Getinge (Maquet), Medtronic, Terumo CV Group, and Braile Biomedica, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Artificial Cardiopulmonary Machine market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Single Roller Pump HLM
Double Roller Pump HLM
Market segment by Application can be divided into
Cardiac Surgery
Lung Transplant Operation
Acute Respiratory Failure Treatment
Others
The key market players for global Artificial Cardiopulmonary Machine market are listed below:
LivaNova (Sorin)
Getinge (Maquet)
Medtronic
Terumo CV Group
Braile Biomedica
Tianjin Medical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Artificial Cardiopulmonary Machine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Artificial Cardiopulmonary Machine, with price, sales, revenue and global market share of Artificial Cardiopulmonary Machine from 2019 to 2022.
Chapter 3, the Artificial Cardiopulmonary Machine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Artificial Cardiopulmonary Machine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Artificial Cardiopulmonary Machine market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Artificial Cardiopulmonary Machine.
Chapter 13, 14, and 15, to describe Artificial Cardiopulmonary Machine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Geographical Area
Global
Index1 Market Overview
1.1 Artificial Cardiopulmonary Machine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Artificial Cardiopulmonary Machine Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Single Roller Pump HLM
1.2.3 Double Roller Pump HLM
1.3 Market Analysis by Application
1.3.1 Overview: Global Artificial Cardiopulmonary Machine Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Cardiac Surgery
1.3.3 Lung Transplant Operation
1.3.4 Acute Respiratory Failure Treatment
1.3.5 Others
1.4 Global Artificial Cardiopulmonary Machine Market Size & Forecast
1.4.1 Global Artificial Cardiopulmonary Machine Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Artificial Cardiopulmonary Machine Sales in Volume (2017-2028)
1.4.3 Global Artificial Cardiopulmonary Machine Price (2017-2028)
1.5 Global Artificial Cardiopulmonary Machine Production Capacity Analysis
1.5.1 Global Artificial Cardiopulmonary Machine Total Production Capacity (2017-2028)
1.5.2 Global Artificial Cardiopulmonary Machine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Artificial Cardiopulmonary Machine Market Drivers
1.6.2 Artificial Cardiopulmonary Machine Market Restraints
1.6.3 Artificial Cardiopulmonary Machine Trends Analysis
2 Manufacturers Profiles
2.1 LivaNova (Sorin)
2.1.1 LivaNova (Sorin) Details
2.1.2 LivaNova (Sorin) Major Business
2.1.3 LivaNova (Sorin) Artificial Cardiopulmonary Machine Product and Services
2.1.4 LivaNova (Sorin) Artificial Cardiopulmonary Machine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Getinge (Maquet)
2.2.1 Getinge (Maquet) Details
2.2.2 Getinge (Maquet) Major Business
2.2.3 Getinge (Maquet) Artificial Cardiopulmonary Machine Product and Services
2.2.4 Getinge (Maquet) Artificial Cardiopulmonary Machine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Medtronic
2.3.1 Medtronic Details
2.3.2 Medtronic Major Business
2.3.3 Medtronic Artificial Cardiopulmonary Machine Product and Services
2.3.4 Medtronic Artificial Cardiopulmonary Machine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Terumo CV Group
2.4.1 Terumo CV Group Details
2.4.2 Terumo CV Group Major Business
2.4.3 Terumo CV Group Artificial Cardiopulmonary Machine Product and Services
2.4.4 Terumo CV Group Artificial Cardiopulmonary Machine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Braile Biomedica
2.5.1 Braile Biomedica Details
2.5.2 Braile Biomedica Major Business
2.5.3 Braile Biomedica Artificial Cardiopulmonary Machine Product and Services
2.5.4 Braile Biomedica Artificial Cardiopulmonary Machine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Tianjin Medical
2.6.1 Tianjin Medical Details
2.6.2 Tianjin Medical Major Business
2.6.3 Tianjin Medical Artificial Cardiopulmonary Machine Product and Services
2.6.4 Tianjin Medical Artificial Cardiopulmonary Machine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Artificial Cardiopulmonary Machine Breakdown Data by Manufacturer
3.1 Global Artificial Cardiopulmonary Machine Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Artificial Cardiopulmonary Machine Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Artificial Cardiopulmonary Machine
3.4 Market Concentration Rate
3.4.1 Top 3 Artificial Cardiopulmonary Machine Manufacturer Market Share in 2021
3.4.2 Top 6 Artificial Cardiopulmonary Machine Manufacturer Market Share in 2021
3.5 Global Artificial Cardiopulmonary Machine Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Artificial Cardiopulmonary Machine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Artificial Cardiopulmonary Machine Market Size by Region
4.1.1 Global Artificial Cardiopulmonary Machine Sales in Volume by Region (2017-2028)
4.1.2 Global Artificial Cardiopulmonary Machine Revenue by Region (2017-2028)
4.2 North America Artificial Cardiopulmonary Machine Revenue (2017-2028)
4.3 Europe Artificial Cardiopulmonary Machine Revenue (2017-2028)
4.4 Asia-Pacific Artificial Cardiopulmonary Machine Revenue (2017-2028)
4.5 South America Artificial Cardiopulmonary Machine Revenue (2017-2028)
4.6 Middle East and Africa Artificial Cardiopulmonary Machine Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Artificial Cardiopulmonary Machine Sales in Volume by Type (2017-2028)
5.2 Global Artificial Cardiopulmonary Machine Revenue by Type (2017-2028)
5.3 Global Artificial Cardiopulmonary Machine Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Artificial Cardiopulmonary Machine Sales in Volume by Application (2017-2028)
6.2 Global Artificial Cardiopulmonary Machine Revenue by Application (2017-2028)
6.3 Global Artificial Cardiopulmonary Machine Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Artificial Cardiopulmonary Machine Sales by Type (2017-2028)
7.2 North America Artificial Cardiopulmonary Machine Sales by Application (2017-2028)
7.3 North America Artificial Cardiopulmonary Machine Market Size by Country
7.3.1 North America Artificial Cardiopulmonary Machine Sales in Volume by Country (2017-2028)
7.3.2 North America Artificial Cardiopulmonary Machine Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Artificial Cardiopulmonary Machine Sales by Type (2017-2028)
8.2 Europe Artificial Cardiopulmonary Machine Sales by Application (2017-2028)
8.3 Europe Artificial Cardiopulmonary Machine Market Size by Country
8.3.1 Europe Artificial Cardiopulmonary Machine Sales in Volume by Country (2017-2028)
8.3.2 Europe Artificial Cardiopulmonary Machine Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Artificial Cardiopulmonary Machine Sales by Type (2017-2028)
9.2 Asia-Pacific Artificial Cardiopulmonary Machine Sales by Application (2017-2028)
9.3 Asia-Pacific Artificial Cardiopulmonary Machine Market Size by Region
9.3.1 Asia-Pacific Artificial Cardiopulmonary Machine Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Artificial Cardiopulmonary Machine Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Artificial Cardiopulmonary Machine Sales by Type (2017-2028)
10.2 South America Artificial Cardiopulmonary Machine Sales by Application (2017-2028)
10.3 South America Artificial Cardiopulmonary Machine Market Size by Country
10.3.1 South America Artificial Cardiopulmonary Machine Sales in Volume by Country (2017-2028)
10.3.2 South America Artificial Cardiopulmonary Machine Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Artificial Cardiopulmonary Machine Sales by Type (2017-2028)
11.2 Middle East & Africa Artificial Cardiopulmonary Machine Sales by Application (2017-2028)
11.3 Middle East & Africa Artificial Cardiopulmonary Machine Market Size by Country
11.3.1 Middle East & Africa Artificial Cardiopulmonary Machine Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Artificial Cardiopulmonary Machine Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Artificial Cardiopulmonary Machine and Key Manufacturers
12.2 Manufacturing Costs Percentage of Artificial Cardiopulmonary Machine
12.3 Artificial Cardiopulmonary Machine Production Process
12.4 Artificial Cardiopulmonary Machine Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Artificial Cardiopulmonary Machine Typical Distributors
13.3 Artificial Cardiopulmonary Machine Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of TablesList of Tables
Table 1. Global Artificial Cardiopulmonary Machine Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Artificial Cardiopulmonary Machine Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. LivaNova (Sorin) Basic Information, Manufacturing Base and Competitors
Table 4. LivaNova (Sorin) Major Business
Table 5. LivaNova (Sorin) Artificial Cardiopulmonary Machine Product and Services
Table 6. LivaNova (Sorin) Artificial Cardiopulmonary Machine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Getinge (Maquet) Basic Information, Manufacturing Base and Competitors
Table 8. Getinge (Maquet) Major Business
Table 9. Getinge (Maquet) Artificial Cardiopulmonary Machine Product and Services
Table 10. Getinge (Maquet) Artificial Cardiopulmonary Machine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Medtronic Basic Information, Manufacturing Base and Competitors
Table 12. Medtronic Major Business
Table 13. Medtronic Artificial Cardiopulmonary Machine Product and Services
Table 14. Medtronic Artificial Cardiopulmonary Machine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Terumo CV Group Basic Information, Manufacturing Base and Competitors
Table 16. Terumo CV Group Major Business
Table 17. Terumo CV Group Artificial Cardiopulmonary Machine Product and Services
Table 18. Terumo CV Group Artificial Cardiopulmonary Machine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Braile Biomedica Basic Information, Manufacturing Base and Competitors
Table 20. Braile Biomedica Major Business
Table 21. Braile Biomedica Artificial Cardiopulmonary Machine Product and Services
Table 22. Braile Biomedica Artificial Cardiopulmonary Machine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Tianjin Medical Basic Information, Manufacturing Base and Competitors
Table 24. Tianjin Medical Major Business
Table 25. Tianjin Medical Artificial Cardiopulmonary Machine Product and Services
Table 26. Tianjin Medical Artificial Cardiopulmonary Machine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Global Artificial Cardiopulmonary Machine Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 28. Global Artificial Cardiopulmonary Machine Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 29. Market Position of Manufacturers in Artificial Cardiopulmonary Machine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 30. Global Artificial Cardiopulmonary Machine Production Capacity by Company, (K Units): 2020 VS 2021
Table 31. Head Office and Artificial Cardiopulmonary Machine Production Site of Key Manufacturer
Table 32. Artificial Cardiopulmonary Machine New Entrant and Capacity Expansion Plans
Table 33. Artificial Cardiopulmonary Machine Mergers & Acquisitions in the Past Five Years
Table 34. Global Artificial Cardiopulmonary Machine Sales by Region (2017-2022) & (K Units)
Table 35. Global Artificial Cardiopulmonary Machine Sales by Region (2023-2028) & (K Units)
Table 36. Global Artificial Cardiopulmonary Machine Revenue by Region (2017-2022) & (USD Million)
Table 37. Global Artificial Cardiopulmonary Machine Revenue by Region (2023-2028) & (USD Million)
Table 38. Global Artificial Cardiopulmonary Machine Sales by Type (2017-2022) & (K Units)
Table 39. Global Artificial Cardiopulmonary Machine Sales by Type (2023-2028) & (K Units)
Table 40. Global Artificial Cardiopulmonary Machine Revenue by Type (2017-2022) & (USD Million)
Table 41. Global Artificial Cardiopulmonary Machine Revenue by Type (2023-2028) & (USD Million)
Table 42. Global Artificial Cardiopulmonary Machine Price by Type (2017-2022) & (US$/Unit)
Table 43. Global Artificial Cardiopulmonary Machine Price by Type (2023-2028) & (US$/Unit)
Table 44. Global Artificial Cardiopulmonary Machine Sales by Application (2017-2022) & (K Units)
Table 45. Global Artificial Cardiopulmonary Machine Sales by Application (2023-2028) & (K Units)
Table 46. Global Artificial Cardiopulmonary Machine Revenue by Application (2017-2022) & (USD Million)
Table 47. Global Artificial Cardiopulmonary Machine Revenue by Application (2023-2028) & (USD Million)
Table 48. Global Artificial Cardiopulmonary Machine Price by Application (2017-2022) & (US$/Unit)
Table 49. Global Artificial Cardiopulmonary Machine Price by Application (2023-2028) & (US$/Unit)
Table 50. North America Artificial Cardiopulmonary Machine Sales by Country (2017-2022) & (K Units)
Table 51. North America Artificial Cardiopulmonary Machine Sales by Country (2023-2028) & (K Units)
Table 52. North America Artificial Cardiopulmonary Machine Revenue by Country (2017-2022) & (USD Million)
Table 53. North America Artificial Cardiopulmonary Machine Revenue by Country (2023-2028) & (USD Million)
Table 54. North America Artificial Cardiopulmonary Machine Sales by Type (2017-2022) & (K Units)
Table 55. North America Artificial Cardiopulmonary Machine Sales by Type (2023-2028) & (K Units)
Table 56. North America Artificial Cardiopulmonary Machine Sales by Application (2017-2022) & (K Units)
Table 57. North America Artificial Cardiopulmonary Machine Sales by Application (2023-2028) & (K Units)
Table 58. Europe Artificial Cardiopulmonary Machine Sales by Country (2017-2022) & (K Units)
Table 59. Europe Artificial Cardiopulmonary Machine Sales by Country (2023-2028) & (K Units)
Table 60. Europe Artificial Cardiopulmonary Machine Revenue by Country (2017-2022) & (USD Million)
Table 61. Europe Artificial Cardiopulmonary Machine Revenue by Country (2023-2028) & (USD Million)
Table 62. Europe Artificial Cardiopulmonary Machine Sales by Type (2017-2022) & (K Units)
Table 63. Europe Artificial Cardiopulmonary Machine Sales by Type (2023-2028) & (K Units)
Table 64. Europe Artificial Cardiopulmonary Machine Sales by Application (2017-2022) & (K Units)
Table 65. Europe Artificial Cardiopulmonary Machine Sales by Application (2023-2028) & (K Units)
Table 66. Asia-Pacific Artificial Cardiopulmonary Machine Sales by Region (2017-2022) & (K Units)
Table 67. Asia-Pacific Artificial Cardiopulmonary Machine Sales by Region (2023-2028) & (K Units)
Table 68. Asia-Pacific Artificial Cardiopulmonary Machine Revenue by Region (2017-2022) & (USD Million)
Table 69. Asia-Pacific Artificial Cardiopulmonary Machine Revenue by Region (2023-2028) & (USD Million)
Table 70. Asia-Pacific Artificial Cardiopulmonary Machine Sales by Type (2017-2022) & (K Units)
Table 71. Asia-Pacific Artificial Cardiopulmonary Machine Sales by Type (2023-2028) & (K Units)
Table 72. Asia-Pacific Artificial Cardiopulmonary Machine Sales by Application (2017-2022) & (K Units)
Table 73. Asia-Pacific Artificial Cardiopulmonary Machine Sales by Application (2023-2028) & (K Units)
Table 74. South America Artificial Cardiopulmonary Machine Sales by Country (2017-2022) & (K Units)
Table 75. South America Artificial Cardiopulmonary Machine Sales by Country (2023-2028) & (K Units)
Table 76. South America Artificial Cardiopulmonary Machine Revenue by Country (2017-2022) & (USD Million)
Table 77. South America Artificial Cardiopulmonary Machine Revenue by Country (2023-2028) & (USD Million)
Table 78. South America Artificial Cardiopulmonary Machine Sales by Type (2017-2022) & (K Units)
Table 79. South America Artificial Cardiopulmonary Machine Sales by Type (2023-2028) & (K Units)
Table 80. South America Artificial Cardiopulmonary Machine Sales by Application (2017-2022) & (K Units)
Table 81. South America Artificial Cardiopulmonary Machine Sales by Application (2023-2028) & (K Units)
Table 82. Middle East & Africa Artificial Cardiopulmonary Machine Sales by Region (2017-2022) & (K Units)
Table 83. Middle East & Africa Artificial Cardiopulmonary Machine Sales by Region (2023-2028) & (K Units)
Table 84. Middle East & Africa Artificial Cardiopulmonary Machine Revenue by Region (2017-2022) & (USD Million)
Table 85. Middle East & Africa Artificial Cardiopulmonary Machine Revenue by Region (2023-2028) & (USD Million)
Table 86. Middle East & Africa Artificial Cardiopulmonary Machine Sales by Type (2017-2022) & (K Units)
Table 87. Middle East & Africa Artificial Cardiopulmonary Machine Sales by Type (2023-2028) & (K Units)
Table 88. Middle East & Africa Artificial Cardiopulmonary Machine Sales by Application (2017-2022) & (K Units)
Table 89. Middle East & Africa Artificial Cardiopulmonary Machine Sales by Application (2023-2028) & (K Units)
Table 90. Artificial Cardiopulmonary Machine Raw Material
Table 91. Key Manufacturers of Artificial Cardiopulmonary Machine Raw Materials
Table 92. Direct Channel Pros & Cons
Table 93. Indirect Channel Pros & Cons
Table 94. Artificial Cardiopulmonary Machine Typical Distributors
Table 95. Artificial Cardiopulmonary Machine Typical Customers
List of Figures
Figure 1. Artificial Cardiopulmonary Machine Picture
Figure 2. Global Artificial Cardiopulmonary Machine Revenue Market Share by Type in 2021
Figure 3. Single Roller Pump HLM
Figure 4. Double Roller Pump HLM
Figure 5. Global Artificial Cardiopulmonary Machine Revenue Market Share by Application in 2021
Figure 6. Cardiac Surgery
Figure 7. Lung Transplant Operation
Figure 8. Acute Respiratory Failure Treatment
Figure 9. Others
Figure 10. Global Artificial Cardiopulmonary Machine Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 11. Global Artificial Cardiopulmonary Machine Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global Artificial Cardiopulmonary Machine Sales (2017-2028) & (K Units)
Figure 13. Global Artificial Cardiopulmonary Machine Price (2017-2028) & (US$/Unit)
Figure 14. Global Artificial Cardiopulmonary Machine Production Capacity (2017-2028) & (K Units)
Figure 15. Global Artificial Cardiopulmonary Machine Production Capacity by Geographic Region: 2022 VS 2028
Figure 16. Artificial Cardiopulmonary Machine Market Drivers
Figure 17. Artificial Cardiopulmonary Machine Market Restraints
Figure 18. Artificial Cardiopulmonary Machine Market Trends
Figure 19. Global Artificial Cardiopulmonary Machine Sales Market Share by Manufacturer in 2021
Figure 20. Global Artificial Cardiopulmonary Machine Revenue Market Share by Manufacturer in 2021
Figure 21. Artificial Cardiopulmonary Machine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 22. Top 3 Artificial Cardiopulmonary Machine Manufacturer (Revenue) Market Share in 2021
Figure 23. Top 6 Artificial Cardiopulmonary Machine Manufacturer (Revenue) Market Share in 2021
Figure 24. Global Artificial Cardiopulmonary Machine Sales Market Share by Region (2017-2028)
Figure 25. Global Artificial Cardiopulmonary Machine Revenue Market Share by Region (2017-2028)
Figure 26. North America Artificial Cardiopulmonary Machine Revenue (2017-2028) & (USD Million)
Figure 27. Europe Artificial Cardiopulmonary Machine Revenue (2017-2028) & (USD Million)
Figure 28. Asia-Pacific Artificial Cardiopulmonary Machine Revenue (2017-2028) & (USD Million)
Figure 29. South America Artificial Cardiopulmonary Machine Revenue (2017-2028) & (USD Million)
Figure 30. Middle East & Africa Artificial Cardiopulmonary Machine Revenue (2017-2028) & (USD Million)
Figure 31. Global Artificial Cardiopulmonary Machine Sales Market Share by Type (2017-2028)
Figure 32. Global Artificial Cardiopulmonary Machine Revenue Market Share by Type (2017-2028)
Figure 33. Global Artificial Cardiopulmonary Machine Price by Type (2017-2028) & (US$/Unit)
Figure 34. Global Artificial Cardiopulmonary Machine Sales Market Share by Application (2017-2028)
Figure 35. Global Artificial Cardiopulmonary Machine Revenue Market Share by Application (2017-2028)
Figure 36. Global Artificial Cardiopulmonary Machine Price by Application (2017-2028) & (US$/Unit)
Figure 37. North America Artificial Cardiopulmonary Machine Sales Market Share by Type (2017-2028)
Figure 38. North America Artificial Cardiopulmonary Machine Sales Market Share by Application (2017-2028)
Figure 39. North America Artificial Cardiopulmonary Machine Sales Market Share by Country (2017-2028)
Figure 40. North America Artificial Cardiopulmonary Machine Revenue Market Share by Country (2017-2028)
Figure 41. United States Artificial Cardiopulmonary Machine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Canada Artificial Cardiopulmonary Machine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Mexico Artificial Cardiopulmonary Machine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Europe Artificial Cardiopulmonary Machine Sales Market Share by Type (2017-2028)
Figure 45. Europe Artificial Cardiopulmonary Machine Sales Market Share by Application (2017-2028)
Figure 46. Europe Artificial Cardiopulmonary Machine Sales Market Share by Country (2017-2028)
Figure 47. Europe Artificial Cardiopulmonary Machine Revenue Market Share by Country (2017-2028)
Figure 48. Germany Artificial Cardiopulmonary Machine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. France Artificial Cardiopulmonary Machine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. United Kingdom Artificial Cardiopulmonary Machine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Russia Artificial Cardiopulmonary Machine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Italy Artificial Cardiopulmonary Machine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Asia-Pacific Artificial Cardiopulmonary Machine Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Artificial Cardiopulmonary Machine Sales Market Share by Application (2017-2028)
Figure 55. Asia-Pacific Artificial Cardiopulmonary Machine Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Artificial Cardiopulmonary Machine Revenue Market Share by Region (2017-2028)
Figure 57. China Artificial Cardiopulmonary Machine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Japan Artificial Cardiopulmonary Machine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Korea Artificial Cardiopulmonary Machine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. India Artificial Cardiopulmonary Machine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Southeast Asia Artificial Cardiopulmonary Machine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Australia Artificial Cardiopulmonary Machine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South America Artificial Cardiopulmonary Machine Sales Market Share by Type (2017-2028)
Figure 64. South America Artificial Cardiopulmonary Machine Sales Market Share by Application (2017-2028)
Figure 65. South America Artificial Cardiopulmonary Machine Sales Market Share by Country (2017-2028)
Figure 66. South America Artificial Cardiopulmonary Machine Revenue Market Share by Country (2017-2028)
Figure 67. Brazil Artificial Cardiopulmonary Machine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina Artificial Cardiopulmonary Machine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East & Africa Artificial Cardiopulmonary Machine Sales Market Share by Type (2017-2028)
Figure 70. Middle East & Africa Artificial Cardiopulmonary Machine Sales Market Share by Application (2017-2028)
Figure 71. Middle East & Africa Artificial Cardiopulmonary Machine Sales Market Share by Region (2017-2028)
Figure 72. Middle East & Africa Artificial Cardiopulmonary Machine Revenue Market Share by Region (2017-2028)
Figure 73. Turkey Artificial Cardiopulmonary Machine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Egypt Artificial Cardiopulmonary Machine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia Artificial Cardiopulmonary Machine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. South Africa Artificial Cardiopulmonary Machine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Manufacturing Cost Structure Analysis of Artificial Cardiopulmonary Machine in 2021
Figure 78. Manufacturing Process Analysis of Artificial Cardiopulmonary Machine
Figure 79. Artificial Cardiopulmonary Machine Industrial Chain
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source
Published By : GlobalInfoResearch
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
